The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes (Q34187249)

31 July 2017

title

The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes (English)

1 reference

31 July 2017

14

Stephen Spellman

1 reference

31 July 2017

13

Michelle Setterholm

1 reference

31 July 2017

6

Richard E Champlin

1 reference

31 July 2017

Nancy H Collins

1

1 reference

31 July 2017

Adrian P Gee

2

1 reference

31 July 2017

April G Durett

3

1 reference

31 July 2017

Fangyu Kan

4

1 reference

31 July 2017

Mei-Jie Zhang

5

1 reference

31 July 2017

Dennis Confer

7

1 reference

31 July 2017

Mary Eapen

8

1 reference

31 July 2017

Alan Howard

9

1 reference

31 July 2017

Roberta King

10

1 reference

31 July 2017

Mary J Laughlin

11

1 reference

31 July 2017

Robert J Plante

12

1 reference

31 July 2017

Carolyn Keever-Taylor

15

1 reference

31 July 2017

John E Wagner

16

1 reference

31 July 2017

Daniel J Weisdorf

17

1 reference

31 July 2017

publication date

12 October 2009

1 reference

Biology of Blood and Marrow Transplantation

31 July 2017

published in

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

253-262

1 reference

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

1994 Consensus Conference on Acute GVHD Grading

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952392

Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation

28 October 2018

1 reference

12 December 2020

CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies

1 reference

12 December 2020

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

12 December 2020

A randomised study of allogeneic transplantation with stem cells from blood or bone marrow

1 reference

12 December 2020

1 reference

12 December 2020

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

12 December 2020

Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts

1 reference

12 December 2020

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

1 reference

12 December 2020

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

12 December 2020

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

1 reference

12 December 2020

Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose

1 reference

12 December 2020

Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation

1 reference

12 December 2020

10.1016/J.BBMT.2009.10.004

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference